[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Praxis Precision Medicines Inc (PRAX)

Praxis Precision Medicines Inc (PRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,081,264
  • Shares Outstanding, K 27,879
  • Annual Sales, $ 0 K
  • Annual Income, $ -303,270 K
  • EBIT $ -357 M
  • EBITDA $ -361 M
  • 60-Month Beta 2.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.23

Options Overview Details

View History
  • Implied Volatility 63.52% (+2.84%)
  • Historical Volatility 90.11%
  • IV Percentile 2%
  • IV Rank 2.42%
  • IV High 177.65% on 07/01/25
  • IV Low 60.68% on 06/04/26
  • Expected Move (DTE 11) 5.36 (2.11%)
  • Put/Call Vol Ratio 0.54
  • Today's Volume 54
  • Volume Avg (30-Day) 93
  • Put/Call OI Ratio 5.43
  • Today's Open Interest 9,872
  • Open Int (30-Day) 10,100
  • Expected Range 248.65 to 259.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-3.88
  • Number of Estimates 8
  • High Estimate $-3.44
  • Low Estimate $-5.83
  • Prior Year $-3.31
  • Growth Rate Est. (year over year) -17.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
252.46 +0.61%
on 06/05/26
366.52 -30.70%
on 05/27/26
-79.30 (-23.79%)
since 05/05/26
3-Month
252.46 +0.61%
on 06/05/26
366.52 -30.70%
on 05/27/26
-56.58 (-18.22%)
since 03/05/26
52-Week
37.19 +582.98%
on 09/08/25
366.52 -30.70%
on 05/27/26
+211.74 (+501.04%)
since 06/05/25

Most Recent Stories

More News
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference

BOSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company,...

PRAX : 254.00 (-4.06%)
Stock Indexes Post New Record Highs Amid AI Enthusiasm

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.13%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.45%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.48%. June E-mini...

MSTR : 120.44 (-6.90%)
DE : 583.44 (-1.40%)
CARR : 67.16 (-2.01%)
ADI : 401.39 (-6.38%)
GLXY : 25.14 (-11.51%)
ALV : 127.56 (-2.13%)
BWA : 72.63 (-5.71%)
COIN : 152.40 (-7.15%)
AMD : 466.38 (-10.86%)
^BTCUSD : 61,612.01 (-0.01%)
PRAX : 254.00 (-4.06%)
SPY : 737.55 (-2.58%)
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, June 02, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today...

PRAX : 254.00 (-4.06%)
Stocks Push Higher on US Labor Market Strength and AI Spending

The S&P 500 Index ($SPX ) (SPY ) today is up +0.24%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.29%. June E-mini S&P futures (ESM26...

MSTR : 120.44 (-6.90%)
ADI : 401.39 (-6.38%)
GLXY : 25.14 (-11.51%)
ALV : 127.56 (-2.13%)
BWA : 72.63 (-5.71%)
COIN : 152.40 (-7.15%)
^BTCUSD : 61,612.01 (-0.01%)
PRAX : 254.00 (-4.06%)
SPY : 737.55 (-2.58%)
ADSK : 229.96 (-1.58%)
DCH : 6.32 (-4.24%)
ORCL : 213.68 (-9.59%)
Stocks Pressured by Uncertainty of US-Iran Ceasefire Prospects

The S&P 500 Index ($SPX ) (SPY ) today is down -0.20%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.33%. June E-mini S&P futures...

AMAT : 453.01 (-9.71%)
GOOGL : 368.53 (-0.98%)
AVGO : 385.73 (-7.92%)
INTU : 296.76 (-1.73%)
ADI : 401.39 (-6.38%)
DDOG : 234.11 (-3.90%)
NU : 11.97 (-1.24%)
TXN : 285.06 (-6.65%)
$IUXX : 28,957.60 (-4.77%)
ASML : 1,641.74 (-6.59%)
ZNU26 : 109-025s (-0.47%)
MSFT : 416.67 (-2.66%)
Praxis Precision Medicines Provides Vormatrigine Program Update

POWER1 Study in highly refractory patients with focal onset seizures did not meet its primary success measure Secondary measure, the 50% response rate, was met and seizure reduction during the second...

PRAX : 254.00 (-4.06%)
Praxis Precision Medicines Q1 Earnings Call Highlights

Praxis Precision Medicines (NASDAQ:PRAX) said it is preparing for two potential U.S. product launches while advancing several late-stage clinical programs, as management outlined first-quarter 2026 results...

PRAX : 254.00 (-4.06%)
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results

FDA accepted the new drug application (NDA) for ulixacaltamide in Essential Tremor with a PDUFA target action date of January 29, 2027, and the NDA for relutrigine, with priority review, in SCN2A and SCN8A...

PRAX : 254.00 (-4.06%)
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today...

PRAX : 254.00 (-4.06%)
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today...

PRAX : 254.00 (-4.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Praxis Precision Medicines Inc. is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis Precision Medicines Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 285.05
2nd Resistance Point 278.23
1st Resistance Point 266.11
Last Price 254.00
1st Support Level 247.17
2nd Support Level 240.35
3rd Support Level 228.23

See More

52-Week High 366.52
Last Price 254.00
Fibonacci 61.8% 240.72
Fibonacci 50% 201.85
Fibonacci 38.2% 162.99
52-Week Low 37.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.